People News: Novartis and Merck

Share this article:
Novartis' Daniel Vasella handed over the chief executive role to Joe Jimenez, who headed the company's pharmaceuticals division, in February. Vasella continues to serve as chairman of the board. The change completes a succession plan which began in 2008. David Epstein, previously head of oncology, replaces Jimenez as head of pharmaceuticals.
 
Merck hired Bridgette P. Heller to head the company's consumer health division. Heller joins Merck from Johnson & Johnson, where she was president of the baby global business unit since 2007. She was previously global president, baby, kids and wound care. At Merck, she will be EVP and president, consumer healthcare, reporting to chairman, president and CEO Dick Clark. She succeeds Stanley F. Barshay, who is retiring.
Share this article:
You must be a registered member of MMM to post a comment.
 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.